MRCK34

Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh · BMFBOVESPA:MRCK34

100.15 BRL1.15 +1.16%

Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh (BMFBOVESPA:MRCK34) last traded at 100.15 BRL, up 1.16% on the day. Over the past year the stock is up 75.70%. Its 52-week range is 55.23 to 102.87. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open102.25

Day range99.70 – 102.87

52-week range55.23 – 102.87

Volume6.37 K

Average volume (10 days)4.31 K

Market cap (USD)368.89 B

P/E166,916.67

EPS (TTM) (USD)0.000116

Dividend yield1.48%

Beta (1 year)−0.2920

Revenue (TTM) (USD)67.39 B

Employees75.00 K

Performance

+8.50%1 week

+3.57%1 month

+20.66%3 months

+42.26%6 months

+38.14%Year to date

+75.70%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Merck Stocks Decline With Higher Target Leaving a New-Launch Scale TestGuruFocus · 02 Nov 2026
Merck Is Maintained at Neutral by Cantor FitzgeraldDow Jones Newswires · 02 Nov 2026
Merck to Present New Data from Its Broad Oral HIV Portfolio and Pipeline at HIV Glasgow 2026BusinessWire · 02 Nov 2026
From Near Miss To Crown Jewel: The Rise, Reign And Road Ahead For Merck's Keytrudadpa-AFX · 01 Nov 2026
Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
Merck Price Target Raised to $175.00/Share From $165.00 by JP MorganDow Jones Newswires · 30 Oct 2026
Merck Stocks Rise 2.6% With Qlex Still Under 10% of Keytruda SalesGuruFocus · 30 Oct 2026
Merck One of Top Large-Cap Biopharma Picks-AnalystBenzinga · 30 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.